NYMOX

Manufacturing · Bahamas · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Bay & Deveaux Sts, Nassau, New Providenc...

Phone Number

(800) 936-9669

Revenue

<$5 Million

Stock Symbol

NYMX

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About NYMOX

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.Explore more
NYMOX's Social MediaPopular SearchesNymox PharmaceuticalNymox Pharmaceutical CorpNymox CorpNymoxSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: NYMXShow more

NYMOX Org Chart

PhoneEmail
JG
Bahamas flag for contact location.

Chief Information Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is NYMOX your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

NYMOX is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

NYMOX is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NYMOX.

NYMOX financials insights

Gather financial insights about NYMOX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2022

Share Placement

$6.4M

See All NYMOX's Financials Insights

NYMOX Tech Stack

A closer look at the technologies used by NYMOX

Most Recent Scoops

New Hire
Executive Move
Executive Moves, New Hire
Funding
New Hire
Executive Move
Mark Staples has joined the company as Vice President, Chemistry, Manufacturing & Controls. Previously, Staples served as Founder & CMC Consultant at Cusp Pharmatech Consulting LLC.
Executive Moves, New Hire
Facilities Relocation / Expansion
NYMOX has announced plans to move its corporate headquarters from the Bahamas to Switzerland.
Facilities Relocation/Expansion
Funding
Funding
See more scoops

Top Manufacturing Companies

Frequently Asked Questions Regarding NYMOX

What is NYMOX's stock symbol?
NYMOX's stock symbol is NYMX
What is NYMOX's official website?
NYMOX's official website is www.nymox.com
What is NYMOX's Revenue?
NYMOX's revenue is <$5 Million
What is NYMOX's SIC code?
NYMOX's SIC: 28,283
What is NYMOX's NAICS code?
NYMOX's NAICS: 32,325
How many employees does NYMOX have?
NYMOX has 1-10 employees
What industry does NYMOX belong to?
NYMOX is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does NYMOX use?
Some of the popular technologies that NYMOX uses are: reCAPTCHA, PHP, Cloudflare Website Optimization, Cloudflare CDN
How do I contact NYMOX?
NYMOX contact info: Phone number: (800) 936-9669 Website: www.nymox.com
What does NYMOX do?

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasi... a, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.Read More

What are NYMOX social media links?
NYMOX Linkedin page
Is NYMOX a public company?
Yes, NYMOX is a public company and is traded under the symbol NYMX
See more information about NYMOX

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.